Rafferty Asset Management
DTIL icon

Rafferty Asset Management’s Precision BioSciences DTIL Stock Holding History

Rafferty Asset Management’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,367
Closed -$1.19M – 1248
2021
Q4 		$1.19M Buy
5,367
+2,551
+91% +$713K 0.01% 800
2021
Q3 		$975K Sell
2,816
-588
-17% -$199K 0.01% 837
2021
Q2 		$1.28M Sell
3,404
-6,025
-64% -$1.81M 0.01% 801
2021
Q1 		$2.93M Buy
9,429
+8,598
+1,035% +$3.01M 0.02% 510
2020
Q4 		$208K Buy
+831
New +$204K ﹤0.01% 981

Other funds holding DTIL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OMC
OUP Management Company Bala Cynwyd, Pennsylvania $44.5M AUM 55.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Rafferty Asset Management's DTIL Position: Q1 2022 in Review

Rafferty Asset Management sold out of Precision BioSciences (DTIL) in Q1 2022, closing a stake of 5,367 shares — an estimated $1.19M sold.

Rafferty Asset Management first reported a position in DTIL in Q4 2020 and held it in 5 quarters. The position peaked at $2.93M in Q1 2021. 152 funds tracked by Wall St. Rank hold DTIL as of Q1 2022.

  • Rafferty Asset Management reported no remaining Precision BioSciences position as of Q1 2022 after selling out during the quarter.
  • Rafferty Asset Management sold 5,367 Precision BioSciences shares in Q1 2022, an estimated $1.19M.
  • Rafferty Asset Management first reported a position in Precision BioSciences in Q4 2020 and held it in 5 quarters.
  • Rafferty Asset Management's Precision BioSciences position peaked at $2.93M in Q1 2021.
  • 152 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2022.

Based on Rafferty Asset Management's 13F filing for Q1 2022, filed 13 May 2022.